AntriaBio

Overview

Pipeline

Overview

Compound Discovery Preclinical Phase I Phase II

RZ358

Intravenous monoclonal antibody for Congenital Hyperinsulinism(orphan designation)
Discovery Phase completed
Pre-Clinical Phase completed
Phase 1 completed
Phase 2 in progress

AB101

Injectable once-weekly basal insulin for type 1 and type 2 diabetes
Discovery Phase completed
Pre-Clinical Phase completed
Phase 1 in progress
Phase 2 not started

RZ402

Oral Plasma Kallikrein Inhibitor for Diabetic Macular Edema
Discovery Phase completed
Pre-Clinical Phase in progress

RZ602

Oral Plasma Kallikrein Inhibitor for Hereditary Angioedema (orphan candidate)
Discovery Phase completed
Pre-Clinical Phase in progress